MedTrace Logo

Harnessing Digital Health to Understand Clinical Trajectories of Opioid Use Disorder

NCT04535583 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2023-11-15

Study results available
· View outcomes & findings →

Summary

The main objective of the study is to evaluate the feasibility of utilizing digital health technology with opioid use disorder (OUD) patients as measured by a 12-week period of continuous assessment using smartphone surveys and digital sensing. In addition, we will examine the utility of 3 types of digital data (Ecological Momentary Assessment (EMA); Digital sensing; and social media data) in predicting OUD treatment retention and buprenorphine medication adherence.

Conditions

  • Opioid-use Disorder

Sponsors & Collaborators

  • National Drug Abuse Treatment Clinical Trials Network

    collaborator NETWORK

  • Dartmouth College

    collaborator OTHER

  • Kaiser Permanente

    collaborator OTHER

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Dartmouth-Hitchcock Medical Center

    lead OTHER

Principal Investigators

  • Lisa A Marsch, PhD · Dartmouth College

  • Cynthia Campbell, PhD · Kaiser Permanente

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-23
Primary Completion
2021-06-12
Completion
2021-09-21

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04535583 on ClinicalTrials.gov